U.S. Imposes Sanctions in Effort to Curb Flow of Fentanyl from China

On August 21, United States Department of Treasury imposed financial sanctions on three Chinese nationals and two companies accused of producing and shipping fentanyl, a deadly synthetic opioid, to the U.S.[1] The sanctioned nationals include Guanhua Zheng, 63, and Fuijing Zheng, 36, a father and son indicted in Ohio last year on charges of producing and smuggling fentanyl and fentanyl-related substances.[2] The third man, Xiaobing Yan, 42, was linked to similar charges in Mississippi in 2017. The two companies were identified as Qinsheng Pharmaceutical Technology and the Zheng Drug Trafficking Organization, both of which are based in Shanghai.